ask="3.290"
ask_size="1000"
average_daily_volume="31508"
bid="2.690"
bid_size="400"
book_value="0.280"
change="-0.108"
change_from_200_day_moving_average="2.072"
change_from_50_day_moving_average="2.224"
change_from_52_week_high="-0.338"
change_From_52_week_low="2.432"
change_in_percent="-3.541%"
close="2.942"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.260"
ebitda="-2.11M"
eps_estimate_current_year="-0.020"
eps_estimate_next_quarter="0.000"
eps_estimate_next_year="-0.020"
ex_dividend_date="N/A"
float_shares="9122000"
high="3.279"
high_52_weeks="3.280"
last_trade_date="2/10/2017"
last_trade_price="2.942"
last_trade_size="1200"
last_trade_time="2:10pm"
low="2.720"
low_52_weeks="0.510"
market_capitalization="39.42M"
moving_average_200_day="0.870"
moving_average_50_day="0.718"
name="XTL Biopharmaceuticals Ltd. - A"
notes="N/A"
one_year_target_price="30.000"
open="3.279"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="+238.105%"
percent_change_from_50_day_moving_average="+309.991%"
percent_change_from_52_week_high="-10.305%"
percent_change_from_52_week_low="+476.863%"
previous_close="3.050"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="10.893"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="13400000"
short_ratio="0.450"
stock_exchange="NCM"
symbol="XTLB"
volume="31202"
weeks_range_52="0.510 - 3.280"
